Measured Wealth Private Client Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$105K Sell
114
-5
-4% -$5.07K 0.03% 230
2025
Q4
$128K Sell
119
-2
-2% -$1.91K 0.03% 233
2025
Q3
$92.3K Sell
121
-216
-64% -$161K 0.02% 250
2025
Q2
$263K Hold
337
0.08% 154
2025
Q1
$278K Sell
337
-18
-5% -$15K 0.09% 140
2024
Q4
$274K Buy
355
+2
+0.6% +$1.66K 0.09% 147
2024
Q3
$313K Sell
353
-660
-65% -$593K 0.1% 132
2024
Q2
$917K Buy
1,013
+16
+2% +$12.8K 0.32% 42
2024
Q1
$776K Sell
997
-515
-34% -$367K 0.27% 60
2023
Q4
$881K Sell
1,512
-60
-4% -$35K 0.32% 42
2023
Q3
$844K Hold
1,572
0.34% 43
2023
Q2
$737K Sell
1,572
-66
-4% -$27.7K 0.28% 45
2023
Q1
$563K Sell
1,638
-616
-27% -$208K 0.22% 70
2022
Q4
$825K Buy
2,254
+242
+12% +$85.8K 0.34% 41
2022
Q3
$651K Sell
2,012
-120
-6% -$38K 0.29% 46
2022
Q2
$691K Buy
2,132
+141
+7% +$42.3K 0.31% 48
2022
Q1
$570K Buy
1,991
+248
+14% +$63.8K 0.21% 59
2021
Q4
$481K Buy
1,743
+54
+3% +$13.7K 0.17% 76
2021
Q3
$390K Buy
1,689
+546
+48% +$135K 0.15% 90
2021
Q2
$262K Hold
1,143
0.08% 150
2021
Q1
$214K Sell
1,143
-400
-26% -$78.2K 0.08% 149
2020
Q4
$261K Hold
1,543
0.11% 111
2020
Q3
$228K Buy
+1,543
New +$239K 0.11% 115
2018
Q4
Sell
-1,123
Closed -$120K 432
2018
Q3
$120K Buy
+1,123
New +$112K 0.07% 209

Other funds holding LLY

Measured Wealth Private Client Group's LLY Position: Q1 2026 in Review

Measured Wealth Private Client Group reduced its Eli Lilly (LLY) stake by 4.2% in Q1 2026, selling an estimated $5.07K and leaving 114 shares worth $105K. The position accounts for 0.03% of the portfolio, ranked #230.

Measured Wealth Private Client Group first reported a position in LLY in Q3 2018 and has held it in 24 quarters since. The position peaked at $917K in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Measured Wealth Private Client Group held 114 shares of Eli Lilly worth $105K as of Q1 2026.
  • Measured Wealth Private Client Group sold 5 Eli Lilly shares in Q1 2026, an estimated $5.07K.
  • Eli Lilly made up 0.03% of Measured Wealth Private Client Group's portfolio in Q1 2026, its #230 holding.
  • Measured Wealth Private Client Group first reported a position in Eli Lilly in Q3 2018 and has held it in 24 quarters since.
  • Measured Wealth Private Client Group's Eli Lilly position peaked at $917K in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Measured Wealth Private Client Group's 13F filing for Q1 2026, filed 13 May 2026.